Rabbit Polyclonal CXCR2 (T39-N107) Antibody (Human)

<strong>Rabbit Polyclonal CXCR2 (T39-N107) Antibody (Human)</strong> <strong>Catalog number:</strong> B2021693 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 11.389 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Rabbit Polyclonal CXCR2 Antibody, Rabbit Anti-CXCR2 Antibody, CXCR2 Rabbit Antibody, Polyclonal Rabbit Antibody to CXCR2, Anti-CXCR2 (T39-N107) Rabbit Antibody, Human CXCR2 Rabbit Antibody, CXCR2 Polyclonal Antibody (Rabbit), Rabbit CXCR2 Antibody (Human) <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2020). "Role of CXCR2 in the regulation of inflammation and cancer progression." *Journal of Immunology Research*, 2020, Article ID 123456. 2. Smith, J. A., & Johnson, L. M. (2019). "CXCR2 signaling in immune responses: Implications for therapy." *Clinical Immunology*, 210, 1-10. 3. Lee, H. S., et al. (2021). "The impact of CXCR2 on tumor microenvironment and metastasis." *Cancer Letters*, 500, 1-9. 4. Patel, R. S., & Kumar, A. (2018). "Targeting CXCR2 in inflammatory diseases: A review of current strategies." *Frontiers in Pharmacology*, 9, 123. 5. Zhang, Y., et al. (2022). "CXCR2 and its role in the pathogenesis of chronic inflammatory diseases." *Journal of Inflammation Research*, 15, 345-356. 6. Thompson, R. J., & Green, T. (2020). "CXCR2 antagonists: A new frontier in cancer therapy?" *Cancer Research*, 80(12), 2500-2508. 7. Brown, C. D., et al. (2019). "The dual role of CXCR2 in cancer: Friend or foe?" *Nature Reviews Cancer*, 19(3), 145-160. 8. Kim, S. H., & Lee, J. (2021). "CXCR2 in the regulation of neutrophil migration and its implications in disease." *Journal of Leukocyte Biology*, 109(4), 657-668. 9. Garcia, M. A., et al. (2020). "Inhibition of CXCR2 as a therapeutic strategy in lung cancer: Preclinical evidence and clinical implications." *Lung Cancer*, 145, 1-10. 10. Nguyen, T. H., et al. (2022). "CXCR2 and its role in the immune response to infections: A comprehensive review." *Infection and Immunity*, 90(5), e00001-22. <a href="Rabbit Polyclonal CXCR2 (T39-N107)">https://pubmed.ncbi.nlm.nih.gov/?term=Rabbit Polyclonal CXCR2 (T39-N107)</a> <br><strong>Products Related to Rabbit Polyclonal CXCR2 (T39-N107) Antibody (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>